Design defect claims against generic drug manufacturers are not preempted by the Federal Food, Drug, and Cosmetic Act.
Bartlett, et al. v. Mutual Pharmaceutical Company, Inc., et al. (Lawyers Weekly No. 01-117-12) (27 pages) (Boudin, J.) (1st Circuit) Appealed from the U.S. District Court for the District of Massachusetts (Docket No. 10-2277) (May 2, 2012).